Navigation Links
Palomar Successful in U.S. Patent Office Re-Examination of Hair Removal Patent
Date:6/15/2009

property rights, factors affecting the Company's future income and resulting ability to utilize its NOLs, and/or other factors, which are detailed from time to time in the Company's SEC reports, including the report on Form 10-K for the year ended December 31, 2008 and the Company's quarterly reports on Form 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

    Contact:
    Kayla Castle
    Investor Relations Manager
    Palomar Medical Technologies, Inc.
    781-993-2411
    kcastle@palomarmedical.com


'/>"/>
SOURCE Palomar Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Palomar Medical Technologies Third Quarter 2007 Financial Results Conference Call and Webcast
2. Palomar and Gillette Extend Launch Decision on Home-Use Light Based Hair Removal Device and Agree to Negotiate New Terms
3. Palomar to Debut New Technology at the American Academy of Dermatology Annual Meeting
4. Palomar Seeks to License Additional Companies to Home-Use Light-Based Hair Removal Technology
5. Palomar to Unveil New Laser-Assisted Liposuction Platform at the American Society for Laser Medicine & Surgery
6. Palomar Medical Technologies to Host Second Quarter 2008 Financial Results Conference Call and Webcast on July 31, 2008
7. Palomar Medical Reports Financial Results for Third Quarter 2008
8. Palomar Medical Technologies and Reliant Technologies Announce Launch of a Fractional Technology Licensing Program
9. Reliant Technologies, and Palomar Medical Technologies, Announce Launch of a Fractional Technology Licensing Program
10. Palomar Medical Technologies to Host Fourth Quarter and Year End 2008 Financial Results Conference Call and Webcast on February 5, 2009
11. Palomar Medical Reports Financial Results for Fourth Quarter and Fiscal Year 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...ormaldehyde used for embalming in the funeral indu...th from myeloid leukemia, according to a new study...he National Cancer Institute . , Previous studie...etic malignancies and brain cancer in anatomists, ... whom may have worked with formaldehyde. , For...
(Date:11/20/2009)...20, 2009Emergency medical service (EMS) providers ...ardiac arrests each year. Only 5 to 10 percent of...etter quality cardiopulmonary resuscitation (CPR) ...iated with better patient outcome. The Resuscitat...cal research network to study prehospital treatmen...
(Date:11/20/2009)... weeks, potentially adding to preemie delivery rat...thDay News) -- Recent reports show that the rate o...ted States. Now, a new study suggests one reason ...s a full-term birth in the first place. , About...considered a baby born at 34 to 36 weeks of gestat...
(Date:11/20/2009)...cases than with seasonal flu , , FRIDAY... are reporting that children with asthma are more ...asonal flu. , "Asthma has been identified as a ...c H1N1 influenza, present in 21 percent to 30 perc...and fellow researchers from the Hospital for Sick ...
(Date:11/20/2009)...e OB/GYN warns against the new breast cancer recom...ces Task Force. These guidelines may be cost-effec...hen is it wrong to be safe than sorry? , ... Task Force recommendations, published in the curr...set off a firestorm in the medical community. Majo...
Breaking Medicine News(10 mins):Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3
...betes Center, global leader in diabetes research, ...Veraxa Health, Inc. as an independent company. //T...lus year history, Veraxa will market the Joslin Vi...nagement of diabetic retinopathy and other ocular ...
...s found that nearly one-third of pregnancies in Sc...ise to prospective parents, who are totally unprep...ys of almost 4,000 women who participated in prena...undergo an abortion, did so after they were caught...
...scular targeting agent completely prevented the de... tested in a preclinical //study, providing early ... tumors in bone, a common destination for a number...ch that this "Trojan Horse" agent, VEGF121/rGel, s...
...ni Ramadoss, Health & Family Welfare Minister has ...s on arbitrary technical barriers in the name of s...and consumers. Dr. Ramadoss was speaking at a two ...t segment of population in most of the developed n...
...research team looking for a cure for Duchenne Musc... which causes wasting of muscles, submitted their ...e by the team of Italian researchers seem to offer...e wasting which usually begins in the lower limbs....
...he heels of a communiqué from Britain about a nove...descent on Britain’s research farm, New Zealand au...sease from British scientists. Britain's Veterinar... Barry O'Neill, the man at the helm of biosceur...
Other Medicine News:Health News:Joslin Diabetes Center Launches Veraxa Health 2Health News:Joslin Diabetes Center Launches Veraxa Health 3Health News:Joslin Diabetes Center Launches Veraxa Health 4Health News:Joslin Diabetes Center Launches Veraxa Health 5Health News:"Trojan Horse" Agent Halts Bone Metastasis in Mice 2Health News:"Trojan Horse" Agent Halts Bone Metastasis in Mice 3Health News:Two Day International Conclave on Traditional Medicine Inaugurated 2Health News:Two Day International Conclave on Traditional Medicine Inaugurated 3
(Date:11/20/2009)...ire/ -- Reportlinker.com announces that a new mark...,, Medical Adhesives and Sealants - A US Marke...4242/Medical-Adhesives-and-Sealants---A-US-Market-...r&utm_campaign=prnewswire ,, The use of m...ce in medical devices and equipments. Cutting edge...
(Date:11/20/2009)...PRNewswire-FirstCall/ -- BD (Becton, Dickinson and...etion of its acquisition of HandyLab, Inc., an Ann...anufactures molecular diagnostic assays and automa... announced an exclusive agreement for BD to develo...ab Jaguar(TM) platform, the first fully integrated...
(Date:11/19/2009)...re/ -- In response to an ever-increasing number of...s, Operation Pangea II, involving 24 countries, wa...anization,s International Medical Products Anti-Co...angers of buying medicines online. ,, The week ...ests and the seizure of thousands of potentially h...
Breaking Medicine Technology:Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2New Audio Podcast Provides an Insider 26apos 3Bs View of the Healthcare System 54307 1New Audio Podcast Provides an Insider 26apos 3Bs View of the Healthcare System 54307 2New Audio Podcast Provides an Insider 26apos 3Bs View of the Healthcare System 54307 3Endo Pharmaceuticals Announces Resignation of Chief Operating Officer 54303 1Endo Pharmaceuticals Announces Resignation of Chief Operating Officer 54303 2CryoLife Receives FDA 510 28k 29 Clearance for SynerGraft 28R 29 Processed Human Cardiac Patch Material 13521 1CryoLife Receives FDA 510 28k 29 Clearance for SynerGraft 28R 29 Processed Human Cardiac Patch Material 13521 2CryoLife Receives FDA 510 28k 29 Clearance for SynerGraft 28R 29 Processed Human Cardiac Patch Material 13521 3CryoLife Receives FDA 510 28k 29 Clearance for SynerGraft 28R 29 Processed Human Cardiac Patch Material 13521 4
...LANTA, Feb. 25 GeoVax Labs, Inc. (OTC,Bulletin Bo...sed biotechnology,company, announced their HIV/AID... into Phase 2a human trials by the HIV Vaccine Tri...ional Institutes of Health (NIH)., GeoVax,s AIDS .../AIDS,vaccine to be selected to move forward into ...
... More Than 100 Groups Apply for Grants to Assist M... NEW YORK, Feb. 21 In an ambitious move to,signif...ng populations,especially vulnerable to HIV, amfAR...the first recipients of funding given out under it...fund 17 grassroots and frontline,organizations in ...
Other Medicine Technology:GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials 2GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials 3GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials 4amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries 2amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries 3
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
...Laboratories is a national reference laboratory an...arch and development. ARUP offers an extensive tes...in clinical and anatomic pathology. Owned by the U...ude more than half of the nation's university teac...
Medicine Products: